Prescription Drugs | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Prescription Drugs

Prescription Drugs Content

385 Results - Showing 281 to 290
PRESS RELEASE

Virtua Health Inc. to Pay $150,000 to Settle Controlled Substances Act Allegations

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and Acting U.S. Attorney for the District of New Jersey Rachael A. Honig announced a nonprofit healthcare system that owns and operates a network of healthcare entities has agreed to pay $150,000...
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...
PRESS RELEASE

Post Falls Doctor Pays $110,000 for Overprescribing Opioids

COEUR D’ALENE – Dr. Eric Benson, an internist practicing medicine in Post Falls, Idaho, agreed to pay $110,000 to resolve allegations that he unlawfully prescribed opioids and other controlled substances to patients between 2014-2021. The settlement, which was based in part on Dr. Benson’s ability to pay, also restricts the...
PRESS RELEASE

Doctor Convicted of Illegally Prescribing Opioids to Patients

SACRAMENTO, Calif. — Physician Edmund Kemprud, 78, of Dublin, was convicted today of 14 counts of illegally prescribing opioids and other controlled substances patients, Acting U.S. Attorney Phillip A. Talbert announced. According to evidence presented at trial, Kemprud was a physician licensed to practice medicine in California and worked in...
PRESS RELEASE

Florida Man Pleads Guilty to Unlawfully Distributing Opioids at His Pain Management Clinic

MIAMI – A Florida man pleaded guilty yesterday to unlawfully distributing opioids at his pain management clinic in Miami, Florida. According to court documents, Habib Geagea Palacios, 40, of Miami, owned a cash-only pain management clinic in Miami, Florida named General Care Center, Inc. At General Care Center, Palacios paid...
PRESS RELEASE

Spokane Naturopath Agrees To Pay $47,700 Civil Penalty

SPOKANE, Washington – Christopher M. Valley, N.D., a Spokane-based naturopathic doctor, has agreed to pay $47,700 to resolve allegations under the Controlled Substances Act that he improperly prescribed controlled substances between December 2015 and December 2020. The Controlled Substances Act regulates certain drugs deemed to pose a risk of abuse...
PRESS RELEASE

Doctor Charged With Accepting Bribes in Exchange for Fentanyl

NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson and Acting U.S. Attorney for the District of New Jersey Rachael A. Honig announced a Monmouth County, New Jersey, doctor was charged today for his participation in a scheme to receive bribes...
PRESS RELEASE

DEA’s National Prescription Drug Take Back Day Brings in nearly 745,000 Pounds of Unneeded Medications

SEATTLE – The Drug Enforcement Administration, along with its law enforcement partners, has removed close to 745,000 pounds of unneeded prescriptions from medicine cabinets across the country as part of DEA’s ongoing commitment to turn the tide against the U.S. opioid epidemic. Following last month’s 21st National Prescription Drug Take...
PRESS RELEASE

Federal Court Orders Tampa Pharmacy to Close in Case Alleging Unlawful Opioid Distribution

MIAMI - A federal court in Florida ordered a Tampa-area pharmacy shut down and prohibited two of its employees from ever owning, managing or operating any business where controlled substances are dispensed. Pursuant to an agreed consent judgment and permanent injunction filed in U.S. District Court for the Middle District...
PRESS RELEASE

Man Indicted for Taking Controlled Substances from Kansas Hospital

KANSAS CITY, Kan. – A federal grand jury in Kansas returned an indictment charging an Overland Park, Kansas, man on two counts of tampering with a consumer product, one count of possession of fentanyl by deception and subterfuge, and one count of possession of hydromorphone by deception and subterfuge. According...

Pagination

  • First page «
  • Previous
  • Page 28
  • Current page 29
  • Page 30
  • Page 31
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster